Fig. 2
From: Efficacy and safety of erenumab in women with a history of menstrual migraine

Change from baseline in monthly acute MSMD among patients with a self-reported history of menstrual migraine who took migraine-specific medications at baseline. Data are shown as LSM with 95% CIs. The gray shaded area represents months 4–6. Abbreviations: CI, confidence interval; LSM, least squares mean; MSMD, migraine-specific medication days